FATAL THROMBOEMBOLISM IN ACUTE PROMYELOCYTIC LEUKEMIA DURING ALL-TRANS-RETINOIC ACID THERAPY COMBINED WITH ANTIFIBRINOLYTIC THERAPY FOR PROPHYLAXIS OF HEMORRHAGE
S. Hashimoto et al., FATAL THROMBOEMBOLISM IN ACUTE PROMYELOCYTIC LEUKEMIA DURING ALL-TRANS-RETINOIC ACID THERAPY COMBINED WITH ANTIFIBRINOLYTIC THERAPY FOR PROPHYLAXIS OF HEMORRHAGE, Leukemia, 8(7), 1994, pp. 1113-1115
In contrast to patients with disseminated intravascular coagulation (D
IC) due to other causes, patients with acute promyelocytic leukemia (A
PL) receiving standard cytotoxic chemotherapy can be treated safely wi
th antifibrinolytic drugs for prophylaxis of hemorrhage, without the o
ccurrence of thromboembolic complications. However, such drugs should
be used cautiously in APL patients who are receiving all-trans retinoi
c acid (ATRA) differentiation therapy. We report here a patient with A
PL who had fatal thromboembolism after receiving ATRA and tranexamic a
cid therapy.